Some potential mechanisms may contribute to PD-L1 overexpression in DLBCL, such as genetic alterations of 9p24.1 or activation of the JAK/STAT pathway [70, 71]. The gene discussed is SOAT1; the disease is diffuse large B-cell lymphoma.